Name | 1,3,2-benzodioxaborole |
Synonyms | Ctecholborane Catecholborane CATECHOLBORANE Benzcatechinborane RARECHEM AK VD 0002 1,3,2-BENZODIOXABOROLE 1,3,2-benzodioxaborole Benzo[d][1,3,2]dioxaborole(1.0M) Catecholborane, 1.0 M solution in THF Catecholborane, Benzo[d][1,3,2]dioxaborole |
CAS | 274-07-7 |
EINECS | 205-991-5 |
InChI | InChI=1/C6H5BO2/c1-2-4-6-5(3-1)8-7-9-6/h1-4,7H |
InChIKey | CENMEJUYOOMFFZ-UHFFFAOYSA-N |
Molecular Formula | C6H5BO2 |
Molar Mass | 119.91 |
Density | 1.125g/mLat 25°C(lit.) |
Melting Point | 12°C(lit.) |
Boling Point | 50°C50mm Hg(lit.) |
Flash Point | 36°F |
Water Solubility | Reacts with water. |
Solubility | Miscible with diethyl ether, tetrahydrofuran, dichloromethane, chloroform, carbon tetrachloride, toluene, and benzene. |
Vapor Presure | 17.554mmHg at 25°C |
Appearance | liquid |
Color | Hazy Colourless |
BRN | 972072 |
Storage Condition | 2-8°C |
Sensitive | Moisture Sensitive |
Refractive Index | n20/D 1.507(lit.) |
Risk Codes | R11 - Highly Flammable R19 - May form explosive peroxides R34 - Causes burns R67 - Vapors may cause drowsiness and dizziness R65 - Harmful: May cause lung damage if swallowed R63 - Possible risk of harm to the unborn child R48/20 - R14 - Reacts violently with water R40 - Limited evidence of a carcinogenic effect R37 - Irritating to the respiratory system |
Safety Description | S26 - In case of contact with eyes, rinse immediately with plenty of water and seek medical advice. S36/37/39 - Wear suitable protective clothing, gloves and eye/face protection. S45 - In case of accident or if you feel unwell, seek medical advice immediately (show the label whenever possible.) S62 - If swallowed, do not induce vomitting; seek medical advice immediately and show this container or label. S16 - Keep away from sources of ignition. S43 - In case of fire use ... (there follows the type of fire-fighting equipment to be used.) |
UN IDs | UN 2924 3/PG 2 |
WGK Germany | 3 |
FLUKA BRAND F CODES | 1-10 |
TSCA | Yes |
HS Code | 29209090 |
Hazard Class | 3 |
Packing Group | II |